Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The examinations for diffuse lung diseases].

K Otake1, A Suwabe, M Tominaga

  • 1The Department of Laboratory Medicine, Yamagata University School of Medicine, Yamagata 990-9585.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gingival Fibroblast-Driven Osteoimmunology via the IL-33-ILC2-IL-13 Axis.

Journal of dental research·2026
Same author

Zinc- and Fluoride-Releasing Bioactive Glass as a Novel Bone Substitute.

Journal of dental research·2024
Same author

The longitudinal effect of the aldehyde dehydrogenase 2*2 allele on the risk for nonalcoholic fatty liver disease.

Nutrition & diabetes·2016
Same author

Associations between the common HNF1A gene variant p.I27L (rs1169288) and risk of type 2 diabetes mellitus are influenced by weight.

Diabetes & metabolism·2014
Same author

Adopting the stage model for smoking acquisition in Japanese adolescents.

Journal of health psychology·2011
Same author

Characterization of Klebsiella pneumoniae producing SHV-12 and DHA-1 beta-lactamases accompanied by carbapenem resistance during hospitalization in a chronic care ward in Japan.

Journal of chemotherapy (Florence, Italy)·2009
Same journal

[The Role of Laboratory Medicine in Hematopoietic Stem Cell Transplantation "Echocardiogram"].

Rinsho byori. The Japanese journal of clinical pathology·2019
Same journal

[The Significance of Pulmonary Function Testing Before and After Allogeneic Stem Cell Transplantation].

Rinsho byori. The Japanese journal of clinical pathology·2019
Same journal

[Blood Transfusion Inspection].

Rinsho byori. The Japanese journal of clinical pathology·2019
Same journal

[The Role of Clinical Laboratory Technicians at Bone Marrow Transplantation : Blood Test].

Rinsho byori. The Japanese journal of clinical pathology·2019
Same journal

[The Foundation of Allogeneic Hematopoietic Stem Cell Transplantation and the Role of Clinical Laboratory Tests in This Field].

Rinsho byori. The Japanese journal of clinical pathology·2019
Same journal

[How to Interpret Data from Routine Laboratory Tests].

Rinsho byori. The Japanese journal of clinical pathology·2019
See all related articles

Idiopathic pulmonary fibrosis (IPF) diagnosis relies on imaging and biopsy. Current serum tests are insufficient for diagnosing IPF or predicting its outcome, highlighting the need for better diagnostic tools.

Area of Science:

  • Pulmonology and Respiratory Medicine
  • Medical Diagnostics

Background:

  • Diffuse lung diseases present as widespread abnormalities on chest X-rays, encompassing various conditions like infections, neoplasms, and idiopathic pulmonary fibrosis (IPF).
  • IPF is a significant respiratory disease characterized by its frequency and challenging treatment.
  • Diagnosis of IPF integrates respiratory function tests, high-resolution computed tomography (HRCT) findings, and histopathological evaluation, with usual interstitial pneumonia (UIP) pattern being crucial.

Observation:

  • Standard serum examinations, including angiotensin-converting enzyme and anti-nuclear antibodies, are primarily used to exclude other diffuse lung diseases.
  • While surfactant protein D (SP-D) and KL-6 show potential for monitoring disease activity, their lack of elevation in early IPF limits their diagnostic utility.
  • Currently, no definitive serum examinations exist for IPF diagnosis, therapeutic effect determination, or prognosis assessment.

Related Experiment Videos

Findings:

  • The established diagnostic criteria for IPF involve a combination of clinical, radiological (HRCT), and histopathological assessments.
  • Existing biomarkers like SP-D and KL-6 are not consistently elevated in early-stage IPF, hindering their application in initial diagnosis.
  • There is a significant gap in reliable and easily accessible serum-based diagnostic and prognostic markers for IPF.

Implications:

  • The absence of definitive serum markers necessitates the continued reliance on invasive procedures like surgical lung biopsy for IPF diagnosis.
  • Improved diagnostic and prognostic tools, potentially including genetic markers, are essential for effective patient management and treatment strategies for IPF.
  • Further research into novel, non-invasive biomarkers is critical to advance the clinical management of idiopathic pulmonary fibrosis.